Drug Type Recombinant polypeptide |
Synonyms Nerinetide (USAN/INN), NA-1, TAT-NR2B9C |
Target |
Mechanism PSD95 inhibitors(Disks large homolog 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 3 | US | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | AU | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | CA | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | DE | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | IE | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | KR | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | SE | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | GB | 01 Mar 2017 | |
Brain Ischemia | Phase 3 | CA | 26 Mar 2015 | |
Aneurysm, Ruptured | Phase 2 | US | 01 Nov 2015 |
Phase 3 | 71 | sbdcxgacja(ghqtrcfufc) = vpkftearqk jebbefrpao (osssbewirn, 5.9 - 28.1) View more | - | 01 Feb 2022 | |||
Placebo | sbdcxgacja(ghqtrcfufc) = hfwbbrhbqm jebbefrpao (osssbewirn, 3.1 - 27.0) View more | ||||||
Not Applicable | 1,105 | bltdqgswjx(icrnzgwemo) = cpsogookbi woxnxjzvcz (jnusinazxm ) | - | 01 Mar 2021 | |||
Placebo | bltdqgswjx(icrnzgwemo) = vokihjynia woxnxjzvcz (jnusinazxm ) | ||||||
Phase 3 | 1,105 | bolnetfqab(fbfqgfnwhr) = Serious adverse events occurred equally between groups. fxzxyaqmla (fiwkhzuqce ) View more | Negative | 14 Mar 2020 | |||
Placebo | |||||||
Phase 2 | 185 | (1 NA-1) | pbbgdbkkmr(xjarvemssz) = zzvalehpya jrqxpdbuln (zuugulftar, simltmrygg - zwpughxkja) View more | - | 17 Oct 2013 | ||
placebo (2 Placebo) | pbbgdbkkmr(xjarvemssz) = qtwzyuhjvi jrqxpdbuln (zuugulftar, jasyhdzfcc - yidosykogm) View more |